Evidence map›Paper›PMID 41928910›Full record

ArticleFrontiers in molecular neuroscience2026

Editorial: Neuroglycobiology.

Cyril Hanus, Robert G Mealer, Liqin Zhao, Thomas S Klarić

Abstract readEditorial
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in molecular neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Cyril HanusInstitute of Psychiatry and Neurosciences of Paris, Paris-Cité University, INSERM UMR 1266, Paris, France.
Robert G MealerDepartment of Psychiatry, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.
Liqin ZhaoDepartment of Pharmacology and Toxicology, Neuroscience Graduate Program, University of Kansas, Lawrence, KS, United States.
Thomas S KlarićGenos Glycoscience Research Laboratory, Zagreb, Croatia.

Funding

Reshaping ApoE4 and Alzheimer's Brains with ApoE2R01AG071682 · NIA · UNIVERSITY OF KANSAS LAWRENCE · PI TERUNA J. SIAHAAN, Liqin Zhao · 2022 to 2026
$3.4M
Sporadic Alzheimer's Disease: A Bioenergetic Etiology?R01AG061038 · NIA · UNIVERSITY OF KANSAS LAWRENCE · PI ZHAO, LIQIN · 2019 to 2023
$1.9M
NIA NIH HHS R01 AG061038NIA NIH HHS R01 AG071682
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

apolipoprotein Eextracellular matrixglycosylationhuman milk oligosaccharidesNeuroplastin 65O-mannosylationSanfilippo diseasesialylation

Identifiers

PMID41928910
PMCPMC13038605

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.